TrialJournal of clinical pharmacology2025

Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal Cancer.

Xiaofei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.